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ABSTRACT 
Dog and cat-related wound-infections in humans are common. Capnocytophaga 
canimorsus and Capnocytophaga cynodegmi can be transmitted from dogs and cats to 
humans via bites or scratches. C. canimorsus is considered to be invasive and may cause 
sepsis, meningitis or endocarditis, whereas C. cynodegmi appears to be less virulent and is 
mainly associated with wound-infections. During 2007-2010, I collected clinical isolates of 
animal bite associated Capnocytophaga species, which was used in all projects included in 
this thesis. In study I, we used our collection of n=22 isolates to evaluate the performance 
of the recently introduced MALDI-TOF instrument and compared the results with the 
conventional typing method VITEK2. A species-specific PCR was established and used as 
the reference method. MALDI-TOF analysis identified all blood isolates as C. canimorsus 
and 13/14 wound isolates were identified as C. cynodegmi. Taken together, we found that 
MALDI-TOF was more accurate, faster and more cost-effective than conventional typing 
methods. In study II we analysed the interaction of human serum with C. canimorsus and 
C. cynodegmi. Whole blood and serum bactericidal assays unequivocally showed that both 
C. canimorsus and C. cynodegmi were sensitive to the bactericidal properties of whole 
blood and serum. In study III we continued to work with one of the strains in our collection, 
which could not be typed by the species specific PCR in study I. Whole-genome 
sequencing of the 22 Capnocytophaga species isolates in our collection revealed that the 
non-typable isolate in fact constituted a novel species, which we named “Capnocytophaga 
stomatis”. Finally, in study IV we determined the antibiotic profiles against 
Capnocytophaga spp. Currently, there is a lack of comprehensive knowledge on the 
antibiotic susceptibility patterns for Capnocytophaga spp. Therefore, in study IV, we set 
out to study the antibiotic susceptibility profiles against Capnocytophaga spp. We found 
that two strains of C. cynodegmi and 2 strains of C. stomatis were resistant to amoxicillin-
clavulanate, the first-line antibiotic therapy for animal bite related infections. Detailed 
analysis of whole genome data revealed that these strains carried a previously undescribed 
class D beta-lactamase gene with carbapenemase activity. Thus, our findings suggest that 
animal associated bacteria could serve as a potential reservoir for antibiotic resistance 
genes, which could have clinical implications when treating animal bite associated 
infections. Taken together, the data presented in this thesis may improve diagnosis, increase 
the understanding of the pathogenesis and facilitate correct antibiotic treatment of animal 
bite associated Capnocytophaga infections. 
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1 INTRODUCTION 
Humans have been using animals for their meat, bones, skin, work, service, sports, 
companions, etc. To a certain extent, the interaction between animals and humans have been 
mutually beneficial , which generally have resulted in satisfaction for humans and sometimes 
unintentionally have caused suffering for the animals
1,2
. Naturally, the relationship between 
humans and animals has a prehistoric origin, a heritage from our ancestors. We learned that 
animals could be domesticated for different purposes, e.g. horses as workers and cats and 
dogs as companions
3,4
. 
Alongside these relationships, a microscopic interaction has been going on that certainly have 
affected humans. Pet animals are carriers of bacteria, viruses, parasites and fungi. These 
microorganisms can be transmitted to humans directly, e.g. via bites or scratches or 
indirectly, e.g. via a vector or via contaminated surfaces
5–8
. However, most microorganisms 
are harmless to humans, but some are zoonotic pathogens and potentially dangerous to 
humans, such as the notorious rabies virus, which cause many deaths across the world today
9
. 
The most common zoonoses are summarized in Table 1A and B
9–27
. 
Today, dogs and cats are the most common companion animals and together are responsible 
for the majority of pet-associated infections
28
. These animals carry many different 
microorganisms that do not belong to the human normal flora and our knowledge about most 
of them are very limited
29,8,30
 Figure 1. In addition to the transfer of microorganisms from 
animals to humans, dog and cat-bites can cause significant physical damage, which can 
aggravate and spread the infection, sometimes resulting in fatal outcome
31–34
. 
 
Figure 1. A bacterial culture obtained from a dog's mouth. The growth pattern is typically 
polymicrobial and contains a large number of bacterial species.  
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Table 1A: Common bacterial and fungal zoonoses and their respective reservoir and vector 
(brackets). 
Bacteria Fungi 
Actinobacillus lignieresii (horses) Arthroderma species (cats) 
Aeromonas hydrophila (fish) Basidiobolus ranarum (horses, dogs, sheep) 
Anaplasma phagocytophilum (tick) Blastomyces dermatitidis (VAS) 
Bacillus anthracis ( grass-eating animals) Coccidioides species (VAS) 
Bartonella henselae (cats, fleas) Conidiobolus species (horses, dogs, sheep) 
Bergeyella zoohelcum (dogs, cats) Cryptococcus species (VAS) 
Bordetella pertussis (nonhuman primates) Emmonsia species (rodents) 
Borrelia burgdorferi (tick) Histoplasma capsulatum (cattle, horses) 
Brucella spp (VAS) Lacazia loboi (dolphins) 
Burkholderia spp (horse, mule) Mallassezia species (VAS) 
Campylobacter spp (mostly poultry) Microsporidia species (VAS) 
Capnocytophaga spp (dogs and cats) Microsporum spp (VAS) 
Chlamydophila psittaci (mostly birds) Paracoccidioides spp (VAS) 
Coxiella burnetii (VAS) Pneumocystis spp (rodents, dogs, cats, cattle) 
Ehrlichia chaffeensis (ticks) Sporothrix spp (cats and VAS) 
Erysipelothrix rhusiopathiae (VAS) Talaromyces marneffei (bamboo rats, VAS) 
ESBL
a
 (livestock) Trichophyton spp (VAS) 
Francisella tularensis (rodents and VAS)  
Leptospira interrogans,spp (rodents,VAS)  
Leptospira spp (rodents)  
Listeria monocytogenes (VAS)  
Mycobacterium spp (VAS)  
Mycoplasma spp (livestock)  
Pasteurella spp (VAS)  
Plesiomonas shigelloides (fish)  
Rickettsia (tick,fleas)  
Salmonella spp (poultry, turtle, snake)  
Shigella spp (VAS)  
Spirillum minus (rats)  
Staphylococcus spp, MRSA
b
 (VAS)  
Streptobacillus moniliformis (rat)  
Streptococcus equi (horses, mules)  
Streptococcus zooepidemicus (horse, mule) 
a = Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae   b = Methicillin-
resistant Staphylococcus aureus, VAS = various animal species.   
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Table 1B: Common viral and parasitic zoonoses and their respective reservoir and vector 
(brackets). 
Viruses and Unconventional agents  Parasites 
Aichi virus (row oyster) Anisakis simplex (fish) 
Avian influenza (birds) Babesia microti (tick) 
Bunyavirus (mosquito) Clonorchis sinensis (fish) 
Chikungunya virus (mosquito) Diphyllobothrium latum (fish) 
Colorado tick fever virus (ticks) Echinococcus spp (dogs and VAS) 
Cowpox virus (cats and VAS) Fasciola hepatica (fish,snail) 
Crimean–Congo haemorrhagic fever virus  
(ticks and domestics animals) 
Fasciolopsis buski (pigs, fish) 
Dengue (mosquito) Giardia intestinalis (VAS) 
Dobrava–Belgrade virus (yellow-necked 
mouse) 
Heterophyes heterophyes (fish) 
Eastern equine encephalitis virus (mosquito) Leishmania donovani ( sand flies) 
Ebola virus (mostly fruit bats and VAS) Opisthorchis viverrini (fish) 
Far eastern (ticks) Paragonimus westermani (VAS) 
Foot-and-mouth disease virus (VAS) Plasmodium falciparum/species 
(mosquito) 
Hendra virus (pteropid fruit bats) Pseudoterranova decipiens (fish) 
Hepatit E-virus (pigs) Schistosoma japonicum/species 
(infected snails in water) 
Herpesvirus (macaques) Taenia solium (pigs) 
Japanese encephalitis virus (mosquito) Toxocara canis, T. cati (cats, dogs) 
Lassa virus (rodents) Toxoplasma gondii (cats) 
Lyssaviruses, rabies virus (mostly dogs, 
other infected animal) 
Trichinella spp (pigs) 
Monkeypox virus (macaque)  
Nipah virus (pigs, bats)  
Paramyxovirus type 1 (birds)  
Parapoxvirus (sheep and castles)  
Powassan virus (ticks)  
Prion (Cow,Creutzfeldt-Jakob Disease)  
Puumalavirus (rodents)  
Rift Valley fever (domesticated animals)  
Ross River virus (mosquito)  
Rotavirus (pigs)  
Sochi virus (Black Sea field mouse)  
Tick-borne encephalitis virus   
Venezuelan equine encephalitis virus (mosquito) 
Vesicular stomatitis virus (mosquito)  
West Nile virus (mosquito)   
Western equine encephalitis virus (mosquito)  
Zika virus (mosquitoes)  
VAS = various animal species.  
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1.1 How common are animal bite infections?  
Many of us have or will experience a bite from a pet animal. In USA alone, there are 
approximately 75 million dogs and 57 million cats. Five million incidences of animal bite 
injuries are reported per year and ca 1% of them require medical care
15,35
. 
In Sweden, there are 784 000 dogs and 1 159 000 cats (Svenska Kennelklubben, Statistiska 
centralbyrån 2012). According to the Swedish National Board of Health and Welfare 
(Socialstyrelsen) the absolute majority of all reported animal bites are caused by dogs (80-
90%) and a smaller portion are caused by cats (3-15 %). A cat-bite is usually deeper and thus 
more often associated with an infection. For cat-bites, 30-50% of all cases lead to an 
infection, whereas 2-25% of all dog bites are estimated to cause an infection
15,35,36
. 
1.2 Animal bites – risk factors and medical seeking behaviour 
There are several factors that affect the outcomes after dog- and cat-bites.  The size of the 
animal has great impact on the type and the severity of the physical injury. Generally, a big 
dog causes larger tearing and crushing injuries than smaller dogs. Cats more often cause 
puncture injuries, with a high risk of subsequent infection
33
. 
A prospective study over 5000 cases showed that male and female individuals are at equal 
risk for animal and human bites. Bites of dogs (48%), cats (18%), humans (8%), other 
animals (7%) and human self-bites (19%) were responsible for these injuries and risk for 
infections after cat bites were estimated to be six times higher than after a dog-bite
37
. 
Most patients with superficial wounds do not seek medical attention, whereas those with 
severe injuries need acute medical attention and sometimes are even transported with an 
ambulance to hospital. A third category comprises the “over-anxious” patient who seeks 
medical care immediately after the incident. Patients with superficial wounds more often seek 
medical care when the signs of inflammation and infections have developed. Combined, the 
medical seeking behaviour of animal-bitten individuals introduces a bias in the reporting 
systems and generally it is believed that the number of mild injuries after contact with cats 
and dogs is underestimated
7
. 
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1.3 Wound cultures – a microbiologist’s view 
In addition to the physical injuries, infections can occur after animal bites. These infections 
can range from superficial and localized wound infections to severe life threatening systemic 
infections, such as sepsis
38–40
. The microbial etiology is important since it will guide the 
antibiotic treatment. To obtain a wound specimen for bacterial culture is a well-established 
standard procedure in most healthcare systems worldwide
41
. Clinical bacteriological 
laboratories use standard media, such as agar plates and enrichment broth culture to support 
growth of wound associated bacteria. Most of these wounds are colonized by aerobic and 
anaerobic bacteria Figure 2. The most common aerobic bacteria associated with dog and cat 
bites are Pasteurella species, Staphylococcus species, Streptococcus species, Neisseria 
species, Corynebacterium species, Moraxella species, Enterococcus species, Bacillus species 
and Pseudomonas species. The most common anaerobic bacteria are Fusobacterium species, 
Bacteroides species. Porphyromonas species, Prevotella species, Propionibacterium species 
and Peptostreptococcus species
42,43
. 
 
Figure 2. Bacterial culture of a wound specimen after a dog bite wound, showing polymicrobial growth, 
including a mixture of human commensal bacteria and dog oral flora. 
The focus of this thesis is Capnocytophaga species, e.g. Capnocytophaga canimorsus and C. 
cynodegmi, which may be transmitted from dogs and cats to humans. C. canimorsus is 
mainly associated with systemic infections, whereas C. cynodegmi is mostly associated with 
wound infections, although a few cases of C. cynodegmi peritonitis have been reported
44–50
. 
In 1961 the Center for Disease Control and Prevention (CDC) received the first strain of C. 
canimorsus that was isolated from the blood of a splenectomised boy. From 1961 to 1975 
CDC received in total 17 blood culture isolates (CDC collection 1961- 1975) with similar. 
phenotypic patterns. These bacteria were classified as “dysgonic fermenter type 2 (DF-
2)”48,51,52. In 1976, Bobo and Newton published the first case report “A previously 
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undescribed gram-negative bacillus causes septicaemia and meningitis”53. It was first in 1989 
that Don J. Brenner genetically and phenotypically characterized DF-2 and“DF-2 like” 
bacteria and the names Capnocytophaga canimorsus and C. cynodegmi were proposed for 
DF-2 and “DF-2 like”, respectively51 .Capnocytophaga is derived from Latin; bacteria 
requiring (eating) carbon dioxide. Canimorsus: Cani; dog, morsus; bite and Cynodegmi is 
derived from Greek: Kyno; dog, degmos; bite
51
. In addition to C. canimorsus and C. 
cynodegmi, Capnocytophaga canis has recently been described as a member of the normal 
flora of the oral cavity of healthy dogs
54
.  
The prevalence of C. canimorsus and C. cynodegmi in dogs and cats has been determined. C. 
canimorsus can be found in 74% of dogs and 57% of cats and C. cynodegmi can be found in 
86%-96% of dogs and in 84% of cats
55,56
.  
1.4 Epidemiology and clinical records  
The epidemiological pattern of the first sepsis cases (CDC collection 1961- 1975) were as 
follows: out of 17 patients, 88% were males, 65% were over 40 years, 30% were 
splenectomised, and 24% had a history of alcohol abuse. In addition, 59% had a history of a 
dog bite and 24% had a history of a reported contact with a dog or other animals
57
. After the 
initial characterization of C. canimorsus by Brenner (1989)
51
, several follow-up reports have 
confirmed that C. canimorsus indeed can cause severe invasive infections. Most reports show 
that C. canimorsus can be transmitted via bites, scratches or via wounds caused by sharp 
objects, such as the teeth of the animal. The incubation period before clinical symptoms are 
present can range from hours to more than one week. Symptoms are similar to those 
occurring in sepsis, such as fever, chills, lethargy, myalgia, diarrhoea, and nausea and 
vomiting. Notably, signs of local wound infections are often not observed
48,51,58
. 
A summary of 2 review papers comprising a total of 99 clinical cases of C. canimorsus sepsis 
showed that 57% of the cases had a history of a dog bite, 3% had a history of a cat bite and 
10-27% were exposed for a dog without being bitten. Interestingly, 11%-17% did not admit 
any animal contact and one individual had been exposed for another animal than a dog or a 
cat. Approximately 1/3 of the sepsis patients were previously healthy individuals, 10-33% 
were asplenic patients, 18-22% had a history of alcohol abuse and 5% were treated with 
corticosteroids. Sepsis was more common in males (70-74%) than in females (25-30%) 
59,60
. 
The most common clinical manifestations of C. canimorsus sepsis included fulminant 
septicaemias with fatal outcome, disseminated intravenous coagulopathy (DIC), meningitis, 
endocarditis and endophtalmitis
33,42,47,48,61–63
. Naturally it would be expected that most C. 
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canimorsus infections should be related to wounds. Unexpectedly, this organism is in fact 
rarely isolated from infected wounds, but rather from blood cultures
48
. Another interesting 
aspect is that despite the fact that children are frequently victims of cat and dog bites, 
especially children aged 5-9
7
, there are no case reports on infections caused by animal 
Capnocytophaga in children. However, there are 2 case reports of Capnocytophaga sepsis in 
infants, a 12-day-old baby and in a 3-month-old new-born baby
48,59,60
. 
1.5 Bacteriology 
The phenotypic profile of DF-2 as originally stated by Brenner et al, showed that DF-2 was a 
slow growing, gram-negative bacilli that required a long incubation time (more than 24h) in 
CO2 atmosphere. It was unable to grow on MacConkey agar. DF-2 was positive for oxidase 
and catalase, glucose, maltose, and lactose and gliding motility test and negative for sucrose 
and mannitol, indole, urease, and nitrate. Most of these tests are obsolete today but especially 
the oxidase and catalase tests have been proven to be very useful also today. C. canimorsus 
and C. cynodegmi are positive for oxidase and catalase, whereas human Capnocytophaga 
species are negative for these tests. In 1989 Don J. Brenner genetically and phenotypically 
characterized DF-2 and DF-2-like bacteria and proposed the names Capnocytophaga 
canimorsus and C. cynodegmi, respectively. C. cynodegmi differs from C. canimorsus by 
having the ability to ferment sucrose, raffinose, inulin, and mellobiose
48,51
 Table 2. 
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Table 2: Biochemical characteristics of Capnocytophaga species. 
Property and Characteristic  C. canimorsus C. cynodegmi Capnocytophaga species 
Habitat animal animal human 
Growth Requirements capnophilic  (5% CO2) 
mesophilic   (30-37
o
C) 
capnophilic  (5% CO2) 
mesophilic    (30-37
o
C) 
capnophilic  (5% CO2) 
mesophilic   (30-37
o
C) 
Gram stain negative negative negative 
Cell shape fusiform rod fusiform rod fusiform rod 
Sporulation none none none 
Gliding motility gliding gliding gliding 
Hemolysis, SBA negative negative negative 
Growth on MacConkey agar negative negative negative 
Indole negative negative negative 
Urease negative negative negative 
Lysine decarboxylase negative negative negative 
Ornithine decarboxylase negative negative negative 
NO3 to NO2 negative variable variable 
NO2 to N2 variable  variable negative 
Hydrolysis of esculin variable positive variable 
Hydrolysis of ONPG positive positive variable 
Arginine dihyrolase  positive  positive negative 
Oxidase positive  positive negative 
Catalas positive  positive negative 
Acid production from    
Inulin negative positive negative 
Sucrose negative positive positive 
Raffinose negative positive variable 
Melibiose negative positive negative 
Glucose positive positive positive 
Maltose positive positive positive 
Fructose variable positive variable 
Lactose positive positive variable 
Xylose negative negative negative 
Mannitol negative negative negative 
Mannose variable positive positive 
Galactose positive  variable variable 
Hydrolysis of glycogen positive variable variable 
Hydrolysis of Starch positive positive variable 
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1.6 The immune system and Capnocytophaga species 
The immune system is classically divided into innate and adaptive immunity. These systems 
work together to detect foreign substances, eliminate pathogens, control the microbiota and 
are involved in maintaining homeostasis within the body. The immune system cleverly fights 
and controls the microorganisms to protect the host. Microorganisms in turn have 
successively evolved a number of different strategies to avoid the immune system, to be part 
of the microbiota or to become a potential pathogen
64–67
. Our contact with bacteria begins 
early; it´s believed that the first contact takes place during birth, likely also during the 
intrauterine life
68–70
. To simplify matters, the contact between the microbe and the host can be 
of two types, inflammatory and non-inflammatory. The inflammatory component occurs 
when a bacteria is crossing host barriers and triggers an immune response. In contrast, the 
non-inflammatory interaction is best exemplified by the normal flora and its interaction with 
the human immune system. Here, a balance is maintained and this commensalism is 
beneficial for both the host and the microorganism; e.g. the host is protected by harmless 
bacteria and the bacteria gain nutrients for growth. Notably, disease may occur when this 
delicate balance is disturbed, such as during injury, exposure to cytostatic drugs or after 
treatment with broad spectrum antibiotics
65,71,72
. 
Infection can also occur when presumably harmless bacteria end up in the wrong location. 
This is one way to look upon infections with Capnocytophaga species, which normally are 
found in the oral flora of healthy dogs and cats. When these bacteria are transferred to 
humans via bites or scratches, a clinical infection is often the result. There is no evidence that 
Capnocytophaga species has the potential to cause invasive infections if the skin or mucus 
barrier is intact. Intact skin and mucous membranes are considered as the first line of 
defences, constituting physical and biochemical defences against invading microorganisms. 
These parts of the immune system constitute a rapid response to invaders and in general 
resulting in the elimination of the invaders. In addition to serving as physical barriers, the 
skin and mucosal surfaces of humans are colonized by large microbial communities, which 
interact with immune system and contribute to the control of invaders
38,73–77
. 
The skin is a very complex organ that contains several cell-types, such as keratinocytes, 
fibroblasts and dendritic cells. Upon recognition of a microbe, these cells produce cytokines 
and antimicrobial peptides (AMPs), which is the first response to a microbial assault. For 
example, a fissure caused by sharp object e.g. animal teeth, can trigger an acute innate 
immune response. Subsequently damage-associated molecular pattern molecules (DAMPs) 
from the host and pathogen-associated molecular patterns (PAMPs) trigger pro-inflammatory 
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reactions. Through pattern recognition receptors (PRRs), like Toll-like receptors on 
keratinocytes, PAMPs and DAMPs will be recognized, which results in production of AMPs, 
the release of chemokines and cytokines, followed by subsequent recruitment and activation 
of macrophages, neutrophils and other leukocytes. These cells and proteins work together to 
eliminate bacteria, remove dead tissue and debris, and finally aid in the wound-healing 
process
74,75,78
. 
1.7 Recognition by innate sensors 
Until now several of PRR have been discovered such NOD-like receptors (NLRs) and Toll-
like receptors (TLRs) which are expressed on e.g. macrophages and dendritic cells. TLRs are 
transmembrane receptors that can recognize fragments of microbes and other antigens such as 
cell debris after injuries. Peptides, nucleic acids and lipid-based molecules have been 
described as ligands for TLRs. In humans, ten TLRs, TLR1-TLR10, have been discovered. 
Different types of TLRs sense different PAMP fragments; TLR1, TLR2, TLR4 and TLR6 
recognize lipid-related structures, whereas TLR3 and TLR7-9 recognize nucleic acids. 
Moreover retinoid acid-inducible gene I (RIG-I), DNA-dependent activator of IFN-regulatory 
factors (DAI) and two nucleotide-binding oligomerization domains (NOD)-like receptors 
(NOD1 and NOD2) are intracellular PRRs that can trigger the immune response to 
intracellular PAMPs and DAMPs
78–81
. 
1.8 The complement system 
It is well known that human serum has a good bactericidal capacity, in particular against 
gram-negative bacteria
82–85
. This bactericidal activity involve antibodies (heat stable 
component of serum) and the complement  (heat labile component of serum)
86–89
. 
The complement system consists of more than 32 components, functioning in the innate and 
adaptive immune systems with a wide range of functions, including antimicrobial activity, 
chemotaxis and activators of immune cells to control inflammatory reactions. Thus, the 
complement system works to “complement” the human immune system. In addition, the 
complement-system is involved also in other processes, such as angiogenesis and synapse 
maturation
90,91
.  
The activation of the complement system is divided into three pathways: the classical, the 
alternative and the lectin pathway. These three pathways activate the lytic pathway, also 
called the membrane attack complex (MAC)
85,92,93
.  
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1.8.1 The classical pathway 
The classical pathway is generally activated by binding of C1, that consist of subunit proteins 
C1q, C1r and C1s, to the FC region of IgM or IgG clusters that have bound antigen; this 
activation is known as the antibody-dependent pathway
82,88,94
. The subunit C1q is a pattern 
recognition molecule (PRM) and can activate the classical pathway by direct binding to 
structures of microorganisms and apoptotic cells. C1q can also activate the classical pathway 
by binding to other PRMs, such as C-reactive protein
95
. The binding of C1q activates C1r and 
C1s, which results in formation of C1qrs, a formation that is highly dependent on the 
presence of calcium-ions to form
96
. Subsequently, C1qrs cleaves the substrates C4 and C4b 
bound C2 to form C4b2a (C3 convertase)
92,97–100
. 
1.8.2 The alternative pathway 
This pathway is activated by binding of the two factors B and D to hydrolysed C3 (C3i), 
which results in formation of C3 convertase (C3bBb). The formation of C3bBb generates 
more C3b, which amplifies the response. Subsequently C3b covalently binds to the surface of 
pathogens, which results in opsonisation of the pathogen and formation of MAC
92,101,102
. 
1.8.3 The lectin pathway 
The discovery of mannan binding protein (MBP), a calcium-dependent lectin, in 1978 
resulted in the discovery of the lectin pathway
103
. It involves the sugar binding molecules 
(lectins) Mannose-binding lectin (MBL) and ficolins 1-3, which function as PRMs. These 
molecules bind to carbohydrates (mannans) on surfaces of pathogens. Similar to C1q these 
PRMs associate with two MBL-associated serine proteases, MASP-1 and MASP2 after 
binding to the antigen. Formation of MBL/MASP-1/MASP-2 complex results in the cleaving 
of C4 and C2 by MASP-2, which subsequently results in formation of a C3 convertase. C3 
convertase cleaves C3 into C3b and C3a. Finally, the binding of C3b to C4bC2a results in 
formation of C4bC2aC3b, a C5 convertase
99,104–106
. 
1.8.4 The membrane attack complex 
One of the most important consequences of complement activation is the formation of C5 
convertase, an enzyme that mediates the cleavage of C5 and the formation of the membrane 
attack complex (MAC) on the surface of pathogens. Formation of MAC on the surface of 
pathogens, e.g. gram-negative bacteria, results in pores in the lipid bilayer, which cause a loss 
of membrane potential and lysis of the pathogen
85
. 
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1.9 The macrophage response to bacteria 
Macrophages are one of the most important effector cells of the innate immune system and 
provide crucial protection against pathogens. Embryo-derived resident macrophages and 
monocytes recruited to the site of infection can act as pro-inflammatory macrophages, active 
phagocytic cells (M1) or they can undergo changes to act as anti-inflammatory macrophages 
(M2), which are implicated in tissue repair. In other words, neither monocytes nor 
macrophages are a homogeneous population of cells. Macrophages have a wide range of 
functions, in addition to their phagocytic capacity. For example, they produce cytokines and 
function as antigen-presenting cells (APC), which makes macrophages an important link to 
the adaptive immunity. Resident and inflammatory macrophages exist in many different 
organs and depending on localization and function these macrophages also have specific 
names, such as alveolar macrophages and liver Kupffer cells 
74,107,108
. Phagocytic capacity is 
the most eminent property of macrophages Figure 3. After engulfing bacteria into their 
phagosomes, these phagosomes fuse with lysosomes and other vesicles, which contain 
antimicrobial effectors, such as AMPs and proteases, to mature into phagolysosomes, a very 
harsh environment for most bacteria. But some pathogens, such as Mycobacterium 
tuberculosis have evolved strategies to avoid phagolysosomes, and can move into the 
cytoplasm before the formation of phagolysosomes occurs. Finally, after having fulfilled their 
task, macrophages are programmed to undergo apoptosis in order to maintain homeostasis 
within the body
74,109,110
. 
 
Figure 3.  C. canimorsus (green = CFSE) inside of macrophage (red = actin is stained with 
Phalloidin and blue = nucleus is stained with DAPI), possibly exploiting the intracellular niche as 
a hiding place from complement activity. (Zangenah et al, unpublished). 
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1.10 The cellular immune response to Capnocytophaga canimorsus 
Generally, the interaction between C. canimorsus and immune-cells are poorly described. In 
1995 Fischer et al published a study on the interactions between C. canimorsus and C. 
cynodegmi with J774 mouse macrophage cells
111
. By electron microscopy, they found C. 
canimorsus and C. cynodegmi within the vacuoles of the macrophages after 48h and 72h, 
respectively. Further, they claimed that the bacteria replicated intracellularly, since there was 
evidence of more than one bacterial cell within the vacuoles and bacterial septation was 
observed on electron micrographs. In addition, a cytotoxic effect was observed for C. 
canimorsus, whereas this property was not observed for C cynodegmi. The cytotoxic effect 
was not induced by endotoxin, according to this study
111
. 
The next study on C. canimorsus and the interaction with immune-cells was not published 
until 2007, when Shin et al published data on the inflammatory response of human and 
mouse macrophages in response to C. canimorsus infection
112
. They found that C. 
canimorsus could survive and multiply in the presence of J774.1 mouse macrophage cells, 
and they could not observe any bacterial internalization. Further, no evidence of cytotoxicity 
was found in this study, which was in contrast to Fisher et al
111,112
 .Interestingly, infected 
J774.1 mouse macrophages did not release tumour necrosis factor (TNF)– α or IL-1 α. Cells 
infected with either live or heat-killed C. canimorsus (Cc5), isolated from a patient with fatal 
septicaemia, produced low levels of IL-6 and IL-10 and C. canimorsus-infected THP-
1(human monocytic cell line) did not release detectable pro-inflammatory cytokines, IL-1β, 
IL-6, IL-8, IFN-γ, TNF- α and macrophage inflammatory protein–1β, suggesting that C. 
canimorsus somehow could avoid immune recognition. Based on these results, Shin et al 
proposed that C. canimorsus exhibited several potent immune-evasive properties, which 
combined could contribute to the severe presentation often observed in C. canimorsus-
sepsis
112
. 
In 2008, a follow-up paper from the same group found that mouse macrophages were highly 
ineffective in taking up and killing C. canimorsus.  Pre-opsonisation with complement did 
not increase the killing effect whereas pre-opsonisation with rabbit sera specifically raised 
against C. canimorsus enhanced the killing. Interestingly J774.1 macrophages treated with 
conditioned medium of C. canimorsus bacterial cultures did not kill E. coli, suggesting that 
there was an anti-phagocytic factor present in C. canimorsus supernatants. Shin et al showed 
that C. canimorsus (strain Cc5) could block the pro-inflammatory response. They found that 
only 2 of 10 C. canimorsus strains could inhibit the pro-inflammatory response (TNF and NO 
release) in J774.1 cells after a challenge with heat killed Y. enterocolitica 
113
. 
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Shin et al reported in 2009 a study on the interaction between C. canimorsus with the human 
complement system and human polymorphonuclear leukocytes (PMNs). They showed that 
three C. canimorsus strains were highly resistant to 10% normal human serum and one strain 
was resistant also to serum from dog and mouse. It was concluded that the complement 
resistant property was a common property of C. canimorsus. Additionally Shin et al reported 
that human PMNs could not take up or kill C. canimorsus (one strain, Cc5, was tested). 
Interestingly, a mutant of Cc5, with a gene-deletion of the enzyme glycosyltransferase, was 
sensitive to PMN uptake and killing as well as susceptible to complement mediated killing 
via the antibody-dependent classical pathway
114
. 
1.11 Capnocytophaga species and human serum 
There are only a few studies that have described the interactions between animal 
Capnocytophaga species and human serum. The focus in previous studies has been on C. 
canimorsus and up to this point; it is not clear whether C. canimorsus is resistant or sensitive 
to human serum. The first report from Butler et al showed that C. canimorsus was resistant to 
rabbit serum
115
 whereas Hicklin in 1987 showed that C. canimorsus was susceptible to 
normal human serum
116
. In contrast to Hicklin, Shin et al. in 2009 showed that C. canimorsus 
was resistant to normal human serum
114
. Clearly, it is not easy to draw firm conclusions from 
these studies. This lack of knowledge on the interaction between C. canimorsus and C. 
cynodegmi with human serum was the rationale for my own work presented in study II where 
I found that all tested strains were indeed killed by human serum in a complement dependent 
way. 
1.12 Clinical examples of a deficient complement system  
Regardless of the susceptibility of Capnocytophaga species to bactericidal activity of normal 
serum, there are conditions that are associated with low levels of complement factors or that 
impair complement system activity. For example, patients with congenital or acquired splenia 
or with a dysfunctional spleen constitute 1/3 of the cases with C. canimorsus sepsis. Asplenic 
patients have an increased risk of post-splenectomy infections and these patients have low 
serum levels of IgM, which is a highly important activator of the classical pathway. Notably, 
it has been shown that IgM memory B cells decline after splenectomy
117
. The most common 
complement deficiencies are: Classical Pathway Deficiencies: C1q, C1s, C2 and C4 
deficiency. Lectin-Pathway Deficiency: MBL deficiencies, L-ficolin. Alternative Pathway 
Deficiency: Factor B, factor D and Properdin deficiency. These conditions have in common 
that they predispose the patient to various bacterial infections. The most striking example is 
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probably C2-deficiency, which is strongly connected to an increased risk for meningococcal 
infection
87,100,118–120
. However, an early diagnosis can initiate full vaccination against 
meningococci and antibiotic prophylaxis, which will be of great clinical value for the 
individual patient. Importantly, there has been little research into the role of these 
complement disorders and their connection to invasive Capnocytophaga species infections. 
Our finding in paper II, where we clearly show that the complement system is a major factor 
in killing Capnocytophaga species in human serum, could form a platform for future studies 
in this area. 
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2 AIMS 
The general aim of the thesis was to study a collection of animal bite associated 
Capnocytophaga species with regard to diagnostic methods, interactions with the immune 
system, genomic relationships and antimicrobial susceptibility patterns.  
Study I 
The aim of study I was to evaluate MALDI-TOF as a novel diagnostic method in the 
identification of animal bite associated Capnocytophaga species. 
Study II 
The aim of study II was to investigate the interaction between human whole blood and serum 
with C. canimorsus and C. cynodegmi and specifically to test whether these bacteria could 
evade the complement system. 
Study III 
The aim of study III was to describe the genomic relationships within the Capnocytophaga 
family by whole genome sequencing and phylogenetic analyses.  
Study IV 
The aim of study IV was to provide a comprehensive and detailed description of the 
antimicrobial susceptibility patterns of animal bite associated Capnocytophaga species. 
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3 METHODS 
In total we had a collection of 22 clinical isolates of Capnocytophaga species collected 
during the years 2005-2010. The reference strains C. canimorsus (ATCC 35978, blood 
isolate), C. cynodegmi (ATCC 49045, wound isolate) were used as controls in all studies. For 
experiments related to the complement system two Salmonella strains; SL3769 with (rfaG-
gene mutant, serum sensitive) and SL3770 (parent strain, serum resistant) were used as 
controls (paper II). 
3.1 Isolation of Capnocytophaga species from wound specimens 
Wound swab samples were taken from specimens where there was a history of a dog or cat 
bite or physical contact with any of these animals. According to routine laboratory 
procedures, these specimens (swabs) were inoculated on four agar plates (haematin, blood x 2 
and CLED). The plates were incubated in CO2, aerobic and anaerobic atmosphere for 48 h. 
The blood- and haematin-agar plates of randomly selected cultures had extended incubation 
times, up to 5 days in 35-36
o
C, 5% CO2, which is normally required for Capnocytophaga to 
form typical colonies (Figure 4A). If a colony was suspected to be a Capnocytophaga, each 
colony was subjected to Gram staining and further sub-cultured. After 48-72 h of incubation 
in 35-36
o
C and 5% CO2, visible colonies were formed. Selected colonies were tested for 
catalase and oxidase. The criteria for Capnocytophaga species were as follows: typical cell 
morphology in microscopy (Figure 4B), i.e. fusiform, gram negative bacilli with pointed 
ends, positive in catalase and oxidase tests. Those isolates that fulfilled these criteria were 
stored in glycerol stocks at −70°C.  Prior to subsequent experiments a small amount of the 
frozen isolate was sub-cultured on haematin or/and blood agar and incubated at 35-36
o
C, 5% 
CO2.  
 
 
 
 18 
 
 
Figure 4A and B. Colonies of C. canimorsus are visible after 48 h incubation on haematin agar plates 
(A). Gram staining of C. canimorsus shows gram negative, fusiform and rod-shaped bacteria (B). 
3.2 Collection of C. canimorsus from blood culture specimens 
All C. canimorsus strains were recovered from blood culture systems at Falun Central 
Hospital and Karolinska University Hospital. According to standard procedures at the 
respective laboratory in Falun Central Hospital and Karolinska University Hospital, Gram 
staining and bacterial cultures were carried out for all positive blood cultures on blood- and 
haematin-agar plates and incubated in CO2, aerobic and anaerobic atmosphere for a minimum 
of 48 h. 
3.3 Identification of Capnocytophaga species by traditional methods 
As described above, the collection used in this thesis was mainly identified based on colony 
morphology and two biochemical tests (catalase and oxidase). These methods are inexpensive 
and not too sophisticated, but have helped microbiologists to describe bacterial species for 
many years. In general, this diagnostic paradigm works well for fast growing bacteria 
(Staphylococcus species, Streptococcus species and Pseudomonas species, for example) and 
can identify the most common and clinically significant bacteria to the species level. 
However, a more detailed identification of fastidious bacteria, such as Capnocytophaga, 
requires additional methods. Traditionally, an extended panel of biochemical tests has been 
used. This was also true for the original identification of Capnocytophaga canimorsus 
51
.  
Based on gram staining, oxidase and catalase tests, I could distinguish animal bite associated 
Capnocytophaga strains from human Capnocytophaga species, which are oxidase and 
catalase negative. To distinguish C. cynodegmi from C. canimorsus, sucrose, raffinose, and 
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mellobiose were used. These tests were performed according to the reference-method and a 
heavy inoculum was used for the fermentations tests, the incubation time was extended up to 
5 days and the incubation occurred in CO2 atmosphere, as recommended in the original 
description
51
. Despite careful and detailed analysis, we found most of these tests to be very 
slow, unreliable and not particularly useful in a clinical context. 
The problems that we confronted with conventional methods were the main rationale for 
study I, where we wanted to improve the diagnostic procedures and evaluated the 
performance of MALDI-TOF in the identification of Capnocytophaga species. 
3.4 MALDI-TOF mass spectrometry analysis 
MALDI-TOF mass spectrometry (MS) has been used for decades in the analysis and 
characterization of biomolecules, such as lipids, DNA, proteins and peptides. In recent years 
MALDI-TOF has been used extensively in clinical laboratories with a wide range of 
applications, such as the identification of bacteria and other microorganisms
121
. In study I we 
evaluated Microflex LT MALDI-TOF system (Bruker Daltonics) and compared its 
performance with traditional methods that have been used in clinical microbiology 
laboratories for identification of Capnocytophaga. A small amount of bacterial colonies were 
collected with plastic loops and applied to a MSP96 polished steel target plate. Next, the 
samples were covered with 2.0 μl of the matrix (saturated α-cyano 4-hydroxy cinnamic acid 
in 50 % acetonitrile with 2.5 % tri flouro acetic acid) and analysed immediately after dryness 
of the sample in MSP96. To collect mass spectra, the FlexControl 3.0 software (Bruker 
Daltonics) with the manufacturer’s pre-settings was used (spectra of m/z range of 2,000 to 
20,000 Daltons). Next, the software MALDI Biotyper (Bruker Daltonics) was used to 
automatically compare the obtained spectrum with a reference spectrum from the database 
provided by the manufacturer. The spectra of the unknown samples were compared with the 
reference spectra and interpreted by the software. A reliable identification was presented as a 
score; a score greater than 1.9 was considered as a correct identification of bacteria to the 
species level and a score of 1.7 to 1.999 considered as a correct identification to the genus 
level. Importantly, the main limitation of the system is the database. If a bacterial species is 
rare and the database contains few reference spectra, there is a lower chance to obtain a high 
score. This was the fact for us when working with paper I. The database only contained one 
spectrum for C. canimorsus and one spectrum for C. cynodegmi, which resulted in low scores 
for most isolates. 
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3.5 Whole blood killing assay 
The classical whole blood bactericidal assay, like serum killing assay, is based on the colony 
counting method, which measures the growth of bacteria in the presence of normal human 
whole blood. In these assays we use heparinized blood from healthy volunteers. Notably, 
some of the most common anticoagulants, such as citrate and EDTA, should not be used 
since these agents can bind calcium in the blood and serum, which would result in the 
inactivation of calcium dependent activities (complement activation) of whole blood and 
serum. 
For the experiments involving whole blood, 900 µl of whole blood (heparinized) was mixed 
with 100 µl bacteria diluted in PBS. These tubes were incubated at 37
o
C, using an end-over-
end rotator at 6 rpm. After 90 min of incubation, the bacteria-blood solution was plated and 
after over-night incubation, viable bacteria were counted. 
3.6 Serum killing assay 
Normal human sera (NHS) from healthy individuals were pooled and used as serum source 
for most of the experiments. Full complement analysis on pooled NHS was performed by the 
Karolinska University Laboratory (Clinical immunology) to confirm the quality of the sera. 
Several controls were used in these experiments (paper II): a) Heat inactivated serum. 
Complement-mediated killing of bacteria is heat sensitive which can be inactivated by 
heating serum for ca 30 min at 56
o
C); b) C1q depleted serum was obtained from Sigma 
(classical pathway is inactivated); c) Serum from MBL deficient patients were obtained from 
the Immunodeficiency Unit, Karolinska University Hospital, Huddinge in relation to another 
study (ethical approval number 2011/116-31/4).  d) EGTA-treated serum. Treating NHS with 
10 mM EGTA-MgCl inhibits the calcium-dependent classical and lectin pathway
122–124
. 
The classical serum killing assay is based on the colony counting method, which measures 
the growth of bacteria in the presence of normal human serum. We used NHS diluted from 
5% to 90% in phosphate buffer solution (PBS). Depending on the serum volume either 
Eppendorf tubes or 96 well microplates were used for the experiments. The growth of 
Capnocytophaga in most nutrient liquid broth, such as brain heart infusion (BHI)-broth was 
insufficient and varied in yield. Therefore we directly harvested Capnocytophaga from agar 
plates and dissolved them in PBS, which is a common procedure for fastidious bacteria
88
. A 
strain was defined as “serum-sensitive” if the viable counts decreased with more than 110log 
compared with the corresponding control. 
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3.7 DNA–DNA hybridizations  
Thermo Scientific GeneJET Genomic DNA Purification Kit was used to isolate DNA from 
24 strains of Capnocytophaga strains, (our collection including two Capnocytophaga 
references). Next, the DNA of these strains was subjected to whole genome sequencing at 
Science for Life Laboratory, Solna, Sweden. Based on genome sequencing, we studied in 
silico the relatedness between these strains by using DNA–DNA hybridization (DDH) 
method. Within microbiology DDH has is useful when 16S rRNA gene sequence similarities 
are too high to distinguish closely related organisms correctly. We used the web server to 
compare the genomes of all strains. The genome of each bacterial isolate was analysed 
against genomes of the other bacteria in the collection. DDH data was obtained by using the 
web server Genome-to-Genome Distance Calculator
125
. 
3.8 Antibiotic susceptibility testing  
The Etest (BioMerieux) was used to determine the susceptibility of Capnocytophaga species 
to several clinically relevant antibiotics. The Etest is the gold standard to determine Minimum 
Inhibitory Concentration (MIC), in particular for resistance testing of slow-growing and 
fastidious bacteria. Prior to the resistance testing, the isolates were sub-cultured from frozen 
stocks onto blood agar for 48 hours, 35
o
C in CO2. Next, the isolates were harvested and 
suspended in sterile PBS to a McFarland standard of 0.5. The suspension was spread on 
blood agar and after dryness (when the suspension had been absorbed into the agar) a single 
Etest strip was applied on agar plate. The agar plates were incubated for 48 hours at 35
o
C in 
CO2. The MIC values were obtained by recording the zones of inhibition. Finally, the MIC 
values were interpreted according to the EUCAST antimicrobial guidelines for non-species 
related breakpoints (http://www.eucast.org/clinical_breakpoints). 
3.9 Identification of antibiotic resistance genes 
To identify antimicrobial resistance genes the web based program ResFinder from the Center 
for Genomic Epidemiology was used. The threshold for ID was set to 98% and the minimum 
length was set to 60%
126
. 
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4 RESULTS AND DISCUSSION  
4.1 Study I 
Rationale: The conventional way to diagnose C. canimorsus and C. cynodegmi was slow, 
unreliable and not useful in a clinical bacteriological laboratory. 
Aim: To evaluate MALDI-TOF as a novel way to identify C. canimorsus and C. cynodegmi. 
Main results: We could show that the classical methods gram staining, oxidase and catalase 
could be used to identify animal Capnocytophaga to preliminary ID, but not to the species 
level. Notably, methods based on biochemical tests or fermentation tubes, including the 
automated typing system VITEK2, could identify some isolates to the genus level but were 
unreliable and ineffective in the identification of Capnocytophaga to species level. 
We also found that C. canimorsus and C. cynodegmi could not be distinguished by 16S rRNA 
sequencing and all strains were identified as C. canimorsus/cynodegmi. This problem 
prompted us to establish a species specific PCR, which enabled us to identify these strains to 
the species level with a high accuracy
127
. 
Importantly, MALDI-TOF MS analysis identified blood isolates as C. canimorsus, whereas 
most wound isolates were identified as C. cynodegmi. 
Notably one strain (W13) was not identified to the species level by using these methods, 
which was further explored in paper III (below). 
Discussion: Capnocytophaga species are common bacteria present in the oral cavity of dogs 
and cats. In association with bites and other types of contact with animals, these bacteria can 
be transmitted to humans and cause infections
45,50,116
. Upon suspicion of infection, a sample 
for bacterial culture is taken and sent to the clinical bacteriological laboratory, which have 
their primary task of providing adequate information about the significant microorganisms 
that may play a role in the progress of the infection
41
. Proper identification and antibiotic 
susceptibility testing of the bacteria are of great importance for treatment and diagnostics
128
. 
Cultivation and biochemical characterization have for a long time been used as the standard 
diagnostic procedure in bacteriological laboratories. However, in recent years these classical 
methods have been complemented with modern diagnostic tools, such as nucleic acid–based 
technologies (DNA sequencing, PCR) and MALDI-TOF MS, which can improve the 
diagnosis of bacterial infections after animal bites
129
. 
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Between 2005-2010, we collected and isolated 22 Capnocytophaga species from blood 
cultures and wound infections. We used this collection to test the performance of MALDI-
TOF MS in the identification of Capnocytophaga species and compared its capacity with 
other established methods in our laboratory. We were aware about the limitations of classical 
methods and the usefulness of MALDI-TOF in clinical bacteriology had been proven for 
many other bacterial species.  
Classical methods are less efficient when diagnosing Capnocytophaga species, due to the 
slow growth of these bacteria. In paper I we showed that MALDI-TOF was superior to 
conventional tests in the identification of almost all strains to the species level. A 
combination of bacterial cultivation and MALDI-TOF seems to be the most efficient way to 
diagnose Capnocytophaga species in clinical laboratories. In particular, MALDI-TOF is a 
rapid and cost effective method but is strongly dependent on the database and available 
reference spectra for the actual species to be identified. 
A reasonable question to ask at this point is why it is important to correctly identify bacteria 
to the species or sub-species level? As a bacteriologist, the natural answer is that it provides 
important information that not only will inform the clinician about various treatment options, 
but also increase the general knowledge about bacteria and diseases caused by bacteria. In 
fact, a correct identification may be crucial for the initiation of the correct antibiotic therapy. 
In addition, a certain species can be linked to a particular disease or condition. This can be 
illustrated by Yersinia intermedia, a bacterium with low pathogenic potential, which is 
similar to Yersinia pestis the causative agent behind the Black Death (Plague)
130
. Finally, in 
our case it is important to correctly identify C. canimorsus, which is associated with sepsis 
whereas the closely related C. cynodegmi is significantly less pathogenic and mainly 
associated with wound infections.  
4.2 Study II 
Rationale: This study was carried out for several reasons: a) Resistance to the complement-
system is considered to be an important virulence factor in Gram-negative bacteria
82
, b) 
Interactions between C. canimorsus and human serum have been studied but there were 
uncertainties whether C. canimorsus is resistant or sensitive to normal human serum; c) There 
was no data on the interaction between C. cynodegmi and human serum and this study could 
thus fill a knowledge gap in the field. 
Aim: To study the growth of C. canimorsus and C. cynodegmi in human whole blood and 
serum. 
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Main results: The results from this study showed that both C. canimorsus and C. cynodegmi 
were killed in the presence of human whole blood and serum. Both the reference strains and 
all tested clinical strains of C. canimorsus and C. cynodegmi were rapidly killed in NHS. 
Further experiments showed that C. canimorsus and C. cynodegmi were killed by different 
complement pathways. C. canimorsus was killed in a classical pathway dependent manner, 
whereas C. cynodegmi was killed by a mechanism that likely involved both the alternative 
and classical pathways. Both C. canimorsus and C. cynodegmi were killed in MBL deficient 
serum, which indicated that the lectin pathway was probably not involved in complement-
mediated killing of Capnocytophaga. In addition, sera from three patients with a history of 
sepsis caused by C. canimorsus were tested against both the autologous strain (C. canimorsus 
isolated from the patient’s blood) and against another C. canimorsus exhibited good killing 
capacity. 
Discussion: Resistance to complement is an important virulence factor in gram negative 
bacteria and to find out if Capnocytophaga species was carrying any complement resistance 
mechanisms, we studied the growth of Capnocytophaga in the presence of whole blood and 
normal human serum. Unexpectedly, we found that all isolates tested were readily killed by 
both whole blood and NHS and that the killing was complement-mediated. This was 
contradicting a previous report where C. canimorsus had been described as resistant to human 
serum and complement
114
. Since the complement system has an important role in the defence 
against invaders it is important not to define “sensitive-bacteria” as “serum-resistant”. In 
addition, none of the Capnocytophaga species strains could survive or grow in MBL deficient 
serum, which indicate that the lectin pathway has a minor role in inhibiting the growth of 
Capnocytophaga species. Inhibition of the classical pathway favoured growth of C. 
canimorsus, which points to a role for IgM. Interestingly, there is possible relationship 
between C. canimorsus sepsis and serum levels of IgM. In particular this could be relevant 
for asplenic patients, which constitute 30% of the clinical cases of C. canimorsus sepsis. 
Asplenic patients have in general low numbers of IgM memory B cells
117,131–133
, which could 
make them more susceptible to infections caused by Capnocytophaga. We performed some 
pilot-experiments with sera from patients with congenital asplenia and sera from two out of 
three individuals failed to kill C. canimorsus (unpublished) Since we know that animal 
Capnocytophaga species are mostly sensitive to human serum it may be of importance to 
check the humoral immune status and concentration of IgM memory B cells of C. canimorsus 
sepsis-patients. It is well known that humoral immunodeficiencies, haematological disorders 
alcohol consumption and metabolic abnormalities have a negative impact on the humoral 
immune status
134–136
. It would be interesting and relevant to study the humoral immune status 
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of C. canimorsus patients, since it could explain the pathogenicity of C. canimorsus and its 
progress to fulminant sepsis. Finally, our study suggests that animal Capnocytophaga species 
are sensitive to normal human serum and we failed to find any complement resistance 
mechanisms. Importantly, health care staffs, people with closes contact with animals and in 
particular people with an age over 40, asplenic individuals as well as alcoholics should be 
aware about C. canimorsus infections. 
Study III  
Rationale: In paper I, one strain could not be unequivocally identified to either C. canimorsus 
or C. cynodegmi, which lead us to hypothesize that there, could be additional species in the 
Capnocytophaga family. 
Aim: To perform whole genome sequencing to study the phylogenetic relationships between 
Capnocytophaga strains. 
Main results: Whole genome sequencing of all strains in our collection, including the recently 
described C. canis, was performed. First, phylogenetic analysis revealed that our previously 
“unidentified strain” W13 clustered together with the recently discovered C. canis. DNA-
DNA hybridization (DDH) analysis showed that W13 had high probability to be a C. canis. 
Next, we found that that three strains (W5, W10 and W12) that previously had been 
identified as C. cynodegmi formed a sister clade to the proper C. cynodegmi-group in the 
phylogenetic tree. 
DDH-analysis revealed that the strains W5, W10 and W12 had low probability we concluded 
that, (0.01–0.09%) to belong to any of the already known Capnocytophaga species. 
Therefore, W5, W10 and W12 represents yet another animal bite associated Capnocytophaga 
species, given the putative name “C. stomatis” by us. 
A detailed phenotypic characterization of the novel species showed that W5, W10 and W12 
as well as W13, just like other Capnocytophaga species, required CO2 for growth, and had 
similar cell morphology in gram staining as other Capnocytophaga species. However, the 
colony morphology differed from the reference strains with regard to size, colour and shape. 
Discussion: In study I we showed the strengths and limitations of different methods in 
identification of Capnocytophaga species. The genetic similarities within the 
Capnocytophaga species family makes it difficult for these tools to distinguish closely related 
species. We faced some difficulty when attempting to identify W13. However, our genomic 
analysis showed that this strain belongs to the recently described species of the C. canis. 
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Additionally, three other isolates were shown to constitute its own group for which we 
proposed the name C. stomatis. This study is the first describing the isolation of two novel 
species, C. canis and C. stomatis, from wounds caused by animal-bites. What is the 
significance of these discoveries? There are several answers to this question. i) A correct 
classification of microorganisms is simply is one way to describe our environment; ii) these 
findings expand our view of the normal flora of pet animals and illustrate the complexity of 
this microbial community; iii) finally, a correct classification of organisms is important from 
an epidemiological perspective since it can contribute to link specific microorganisms to 
certain conditions and diseases. Given the rapid developments in clinical microbiology, we 
anticipate further studies on the diagnosis and pathogenicity of animal bite associated 
Capnocytophaga species. 
Study IV 
Rationale: It is of great importance to initiate appropriate antibiotic therapy to treat wound- 
and systemic infections related to animal bites. 
Aim: To determine the antibiotic profiles against animal Capnocytophaga species. 
Main results: Antimicrobial susceptibility testing by the Etest method confirmed that C. 
canimorsus strains are susceptible to penicillin, cefotaxime, ceftazidime, imipenem and 
doxycycline. Importantly, two strains of C. cynodegmi and two strains of C. stomatis had 
penicillin-resistant phenotypes. The web-based tool, Resfinder, confirmed the presence of a 
class D beta-lactamase gene in these strains, which corresponds to phenotypic penicillin 
resistance. 
Discussion: In this study, we describe the phenotypic and the genotypic resistance profiles of 
Capnocytophaga species, isolated from wound and blood infections related to dog and cat 
bites/contact. Normally prophylactic antibiotics for uncomplicated wounds are not 
recommended, but in the case of high risk to develop infections, first-line oral antibiotic 
therapy is recommended and even intravenous antibiotics may be given for treatment of 
severe infections
33,37,42
. The beta-lactam antibiotic amoxicillin-clavulanate is widely used and 
considered as a first-line antibiotic treatment for dog or cat bite wounds. The risk of 
development of resistance among many different medically important microorganisms is 
known. Here we show that C. cynodegmi and C. stomatis can be resistant to amoxicillin-
clavulanate and the potential consequences of this finding may be difficult to answer today, 
but it is possible that multi-drug resistant Capnocytophaga species may occur in the future. 
Combined, the potentially high virulence connected with Capnocytophaga species together 
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with a risk for antibiotic resistance, we suggest that bacterial cultures always are obtained 
after cat and dog bites and that broad empirical antibiotic therapy is initiated, especially in 
high risk patients. 
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5 CONCLUSIONS 
Study I 
MALDI-TOF with a proper reference database outperforms biochemically based tools, such 
as VITEK2, in the identification of animal bite associated Capnocytophaga species, in 
particular for identification to the species level. MALDI-TOF analysis is an excellent 
complement to classical bacteriological methods within clinical microbiology laboratories by 
virtue of its low cost, user-friendliness and speed. 
Study II 
C. canimorsus and C. cynodegmi are susceptible to human whole blood and human serum in 
a complement-dependent manner.  
Study III 
By using phylogenetic analyses and DNA-DNA hybridization we could identify a novel 
Capnocytophaga species, for which we proposed the name Capnocytophaga stomatis. We 
also found the recently described C. canis in a clinical wound specimen, suggesting that this 
species can be transmitted to humans from both dogs and cats. Combined, these findings 
emphasize the complexity of animal bite infections. 
Study IV 
Both C. cynodegmi and C. stomatis can be resistant to the first line antibiotic treatment 
amoxicillin-clavulanate. Genomic analysis revealed that these strains carried a class D beta-
lactamase gene, with carbapenemase activity, which most likely explained the phenotypic 
resistance patterns with reduced susceptibility to amoxicillin-clavulanate, cefalosporins and 
carbapenems. 
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6 FUTURE PLANS AND PERSPECTIVE  
I will here outline a number of feasible and obvious follow-up studies: 
 (1) The database for MALDI-TOF spectra should be improved for all 
Capnocytophaga species by the addition of a larger collection. This would enable a 
rapid way to obtain a significantly higher precision in the clinical diagnostic 
procedures for animal bite associated Capnocytophaga infections. In particular, it 
would be of value to include the recently discovered species C. canis and C. stomatis. 
 (2) I would like to develop selective agar plates for the isolation of Capnocytophaga 
species from animal bite associated wound specimens. This would greatly increase 
the probability of finding these fastidious bacteria in wound-cultures. Combined, 
project 1 and 2 outlined here would expand the knowledge on the epidemiology, 
antibiotic susceptibility and treatment outcomes of various Capnocytophaga-related 
infections.  
 (3) Since we still think there is a significant under-diagnosis of Capnocytophaga 
canimorsus in sepsis, I would like to investigate if it is possible to improve the growth 
of Capnocytophaga species in blood culture systems that are commercially available. 
The rationale is based on the possibility that not all complement activity is blocked in 
blood culture flasks. If there is residual complement activity left, it is possible that 
further optimization of Capnocytophaga growth is possible. 
 (4) I would also like to study what makes C. canimorsus much more virulent than 
other Capnocytophaga species. I would like to study the immune response of normal 
blood to these bacteria. Does the immune response to C. canimorsus differ from the 
immune response to other Capnocytophaga species i.e. C. cynodegmi, C. canis and C. 
stomatis? 
 (5) Finally, I find it fascinating that children appears to be resistant to C. canimorsus 
sepsis, despite the many bites and scratches that occur in this age-group. It is tempting 
to hypothesize that there is an explanation to find in the immune system of children. It 
would be interesting to monitor the presence and level of antibodies against C. 
canimorsus in children vs adults. In fact, we started to work on the serology of 
Capnocytophaga species by using serum from patients with a history of 
Capnocytophaga sepsis. This could be one way forward to identify unique antigens 
for exposure to C. canimorsus and C. cyndodegmi, respectively. Serology could also 
provide an interesting tool to study the true epidemiology of infections with these 
bacteria.  
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